193 related articles for article (PubMed ID: 35958552)
1. Effect of low-dose rituximab treatment on autoimmune nodopathy with anti-contactin 1 antibody.
Hou Y; Zhang C; Yu X; Wang W; Zhang D; Bai Y; Yan C; Ma L; Li A; Ji J; Cao L; Wang Q
Front Immunol; 2022; 13():939062. PubMed ID: 35958552
[TBL] [Abstract][Full Text] [Related]
2. Autoimmune nodopathy with anti-contactin 1 antibody characterized by cerebellar dysarthria: a case report and literature review.
Chen J; Liu L; Zhu H; Han J; Li R; Gong X; Fu H; Long J; Li H; Meng Q
Front Immunol; 2024; 15():1308068. PubMed ID: 38524138
[TBL] [Abstract][Full Text] [Related]
3. Anti-rituximab antibodies in patients with refractory autoimmune nodopathy with anti-neurofascin-155 antibody.
Bai Y; Li W; Yan C; Hou Y; Wang Q
Front Immunol; 2023; 14():1121705. PubMed ID: 37056784
[TBL] [Abstract][Full Text] [Related]
4. Characteristics of Anti-Contactin1 Antibody-Associated Autoimmune Nodopathies With Concomitant Membranous Nephropathy.
Xu Q; Liu S; Zhang P; Wang Z; Chang X; Liu Y; Yan J; He R; Luo X; Zou LY; Chu X; Guo Y; Huang S; Fu X; Huang Y
Front Immunol; 2021; 12():759187. PubMed ID: 34675937
[TBL] [Abstract][Full Text] [Related]
5. Antibodies to the Caspr1/contactin-1 complex in chronic inflammatory demyelinating polyradiculoneuropathy.
Pascual-Goñi E; Fehmi J; Lleixà C; Martín-Aguilar L; Devaux J; Höftberger R; Delmont E; Doppler K; Sommer C; Radunovic A; Carvajal A; Smyth S; Williams L; Mazanec R; Potočková V; Hinds N; Cassereau J; Viala K; Lefilliatre M; Nicolas G; Foley P; Leypoldt F; Keddie S; Lunn MP; Zimprich F; Nunkoo VS; Löscher WN; Martínez-Martínez L; Díaz-Manera J; Rojas-Garcia R; Illa I; Rinaldi S; Querol L
Brain; 2021 May; 144(4):1183-1196. PubMed ID: 33880507
[TBL] [Abstract][Full Text] [Related]
6. Seropositive Neuromyelitis Optica in a Case of Undiagnosed Ankylosing Spondylitis: A Neuro-Rheumatological Conundrum.
Ghosh Md R; Roy D; León-Ruiz M; Das S; Dubey S; Benito-León J
Qatar Med J; 2022; 2022(3):29. PubMed ID: 35864917
[TBL] [Abstract][Full Text] [Related]
7. Low-dose rituximab treatment in a patient with anti-neurofascin-155 IgG4 autoimmune nodopathy.
Kmezic I; Press R; Glenewinkel H; Doppler K; Appeltshauser L
J Neuroimmunol; 2024 Apr; 389():578326. PubMed ID: 38422690
[TBL] [Abstract][Full Text] [Related]
8. Superior oblique palsy as the initial manifestation of anti-contactin-1 IgG4 autoimmune nodopathy: A case report.
Min YG; Ju W; Sung JJ
J Neuroimmunol; 2024 Apr; 391():578348. PubMed ID: 38688208
[TBL] [Abstract][Full Text] [Related]
9. Chronic Inflammatory Demyelinating Polyneuropathy With Concurrent Membranous Nephropathy: An Anti-paranode and Podocyte Protein Antibody Study and Literature Survey.
Hashimoto Y; Ogata H; Yamasaki R; Sasaguri T; Ko S; Yamashita K; Xu Z; Matsushita T; Tateishi T; Akiyama S; Maruyama S; Yamamoto A; Kira JI
Front Neurol; 2018; 9():997. PubMed ID: 30538665
[No Abstract] [Full Text] [Related]
10. Autoantibody profile in a Malaysian cohort of chronic inflammatory demyelinating polyneuropathy.
Tan CY; Goh KJ; Oh AW; Devaux J; Shahrizaila N
Neuromuscul Disord; 2022 Mar; 32(3):255-262. PubMed ID: 35183410
[TBL] [Abstract][Full Text] [Related]
11. Contactin-1 links autoimmune neuropathy and membranous glomerulonephritis.
Fehmi J; Davies AJ; Antonelou M; Keddie S; Pikkupeura S; Querol L; Delmont E; Cortese A; Franciotta D; Persson S; Barratt J; Pepper R; Farinha F; Rahman A; Canetti D; Gilbertson JA; Rendell NB; Radunovic A; Minton T; Fuller G; Murphy SM; Carr AS; Reilly MR; Eftimov F; Wieske L; Teunissen CE; Roberts ISD; Ashman N; Salama AD; Rinaldi S
PLoS One; 2023; 18(3):e0281156. PubMed ID: 36893151
[TBL] [Abstract][Full Text] [Related]
12. Effect of monovalency on anti-contactin-1 IgG4.
Taieb G; Jentzer A; Vegezzi E; Lleixà C; Illa I; Querol L; Devaux JJ
Front Immunol; 2023; 14():1021513. PubMed ID: 36999029
[TBL] [Abstract][Full Text] [Related]
13. Rituximab in treatment-resistant CIDP with antibodies against paranodal proteins.
Querol L; Rojas-García R; Diaz-Manera J; Barcena J; Pardo J; Ortega-Moreno A; Sedano MJ; Seró-Ballesteros L; Carvajal A; Ortiz N; Gallardo E; Illa I
Neurol Neuroimmunol Neuroinflamm; 2015 Oct; 2(5):e149. PubMed ID: 26401517
[TBL] [Abstract][Full Text] [Related]
14. Autoimmune Neurological Disorders with IgG4 Antibodies: a Distinct Disease Spectrum with Unique IgG4 Functions Responding to Anti-B Cell Therapies.
Dalakas MC
Neurotherapeutics; 2022 Apr; 19(3):741-752. PubMed ID: 35290608
[TBL] [Abstract][Full Text] [Related]
15. Case report: Immunoadsorption therapy for anti-caspr1 antibody-associated nodopathy.
Liu L; Chen J; Zhang Y; Wu J; Hu J; Lin Z
Front Immunol; 2022; 13():986018. PubMed ID: 36211443
[TBL] [Abstract][Full Text] [Related]
16. Clinical relevance of distinguishing autoimmune nodopathies from CIDP: longitudinal assessment in a large cohort.
Broers MC; Wieske L; Erdag E; Gürlek C; Bunschoten C; van Doorn PA; Eftimov F; Kuitwaard K; de Vries JM; de Wit MY; Nagtzaam MM; Franken SC; Zhu L; Paunovic M; de Wit M; Schreurs MW; Lleixà C; Martín-Aguilar L; Pascual-Goñi E; Querol L; Jacobs BC; Huizinga R; Titulaer MJ
J Neurol Neurosurg Psychiatry; 2023 Dec; 95(1):52-60. PubMed ID: 37879898
[TBL] [Abstract][Full Text] [Related]
17. Clinical Features of Autoimmune Nodopathy With Anti-Neurofascin-155 Antibodies in South Koreans.
Lyou HJ; Chung YH; Kim MJ; Kim M; Jeon MY; Kim SW; Shin HY; Kim BJ
J Clin Neurol; 2024 Mar; 20(2):186-193. PubMed ID: 38171501
[TBL] [Abstract][Full Text] [Related]
18. Individualized rituximab treatment for relapsing neuromyelitis optica: a pediatric case report.
He D; Yu Y; Yan W; Dai Q; Xu Z; Chu L
Pediatr Neurol; 2014 Aug; 51(2):255-8. PubMed ID: 25079575
[TBL] [Abstract][Full Text] [Related]
19. Clinical and Laboratory Features in Anti-NF155 Autoimmune Nodopathy.
Martín-Aguilar L; Lleixà C; Pascual-Goñi E; Caballero-Ávila M; Martínez-Martínez L; Díaz-Manera J; Rojas-García R; Cortés-Vicente E; Turon-Sans J; de Luna N; Suárez-Calvet X; Gallardo E; Rajabally Y; Scotton S; Jacobs BC; Baars A; Cortese A; Vegezzi E; Höftberger R; Zimprich F; Roesler C; Nobile-Orazio E; Liberatore G; Hiew FL; Martínez-Piñeiro A; Carvajal A; Piñar-Morales R; Usón-Martín M; Albertí O; López-Pérez MÁ; Márquez F; Pardo-Fernández J; Muñoz-Delgado L; Cabrera-Serrano M; Ortiz N; Bartolomé M; Duman Ö; Bril V; Segura-Chávez D; Pitarokoili K; Steen C; Illa I; Querol L
Neurol Neuroimmunol Neuroinflamm; 2022 Jan; 9(1):. PubMed ID: 34728497
[TBL] [Abstract][Full Text] [Related]
20. A long-term follow-up of rituximab treatment in 20 Chinese patients with neuromyelitis optica spectrum disorders.
Lu Q; Luo J; Hao H; Liu R; Jin H; Jin Y; Gao F
Mult Scler Relat Disord; 2020 May; 40():101933. PubMed ID: 31955136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
